We are live on ! Find out more
EIDX

Eidos Therapeutics, Inc. Common Stock
EIDX

Delisted

EIDX was delisted on the 25th of January, 2021.

Back to rankings

0 hedge funds and large institutions have $0 invested in Eidos Therapeutics, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 120 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 121 → 0 (-121)

100% less funds holding in top 10

Funds holding in top 10: 6 → 0 (-6)

100% less capital invested

Capital invested by funds: $1.45B → $0 (-$1.45B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 120

Holders
–
Holders Change
-121
Holders Change %
-100%
% of All Funds
–
Holding in Top 10
–
Holding in Top 10 Change
-6
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
120
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$205M
2
ACM
Aisling Capital Management
New York
-$148M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$119M
4
PA
Perceptive Advisors
New York
-$90.4M
5
MF
Magnetar Financial
Illinois
-$78.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
– -$152K -1,156 Closed
PNC Financial Services Group
102
PNC Financial Services Group
Pennsylvania
– -$148K -1,120 Closed
AIP
103
Ameritas Investment Partners
Nebraska
– -$124K -939 Closed
PCM
104
Penserra Capital Management
California
– -$117K -890 Closed
OSAM
105
O'Shaughnessy Asset Management
Connecticut
– -$76K -578 Closed
Macquarie Group
106
Macquarie Group
Australia
– -$68K -519 Closed
TRCT
107
Tower Research Capital (TRC)
New York
– -$60K -458 Closed
QT
108
Quantbot Technologies
New York
– -$26K -200 Closed
UBS Group
109
UBS Group
Switzerland
– -$23K -171 Closed
CG
110
Cutler Group
California
– -$22K -170 Closed
HPC
111
HM Payson & Co
Maine
– -$20K -154 Closed
VAIA
112
Virtus Alternative Investment Advisers
Connecticut
– -$16K -124 Closed
PAM
113
Panagora Asset Management
Massachusetts
– -$13K -97 Closed
Daiwa Securities Group
114
Daiwa Securities Group
Japan
– -$10K -73 Closed
VFA
115
Valeo Financial Advisors
Indiana
– -$8K -60 Closed
Royal Bank of Canada
116
Royal Bank of Canada
Ontario, Canada
– -$6K -48 Closed
US Bancorp
117
US Bancorp
Minnesota
– -$3K -21 Closed
LC
118
Lindbrook Capital
California
– -$2K -14 Closed
QCG
119
Quadrant Capital Group
Ohio
– -$1K -8 Closed
1 2 3 4
5

EIDX Hedge Fund Activity: Q1 2021 in Review

0 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Eidos Therapeutics, Inc. Common Stock (EIDX) for Q1 2021, worth a combined $0 — down 100% from $1.45B a quarter earlier.

Sellers outnumbered buyers: 120 funds closed out of EIDX and 0 opened new positions — a net loss of 120 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was BlackRock, exiting entirely with an estimated $205M sold.

  • 0 institutional investors held Eidos Therapeutics, Inc. Common Stock (EIDX) as of Q1 2021, down from 121 in Q4 2020.
  • Funds reported $0 of Eidos Therapeutics, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
  • 0 funds opened new Eidos Therapeutics, Inc. Common Stock positions in Q1 2021 and 120 closed out, a net change of -120 holders.
  • The largest Eidos Therapeutics, Inc. Common Stock seller in Q1 2021 was BlackRock, an estimated $205M sold.

Based on aggregated 13F filings for Q1 2021.